Dynavax Stock Soars 26.4% Today on COVID-19 Vaccine Hopes
Shares of Dynavax Technologies (NASDAQ: DVAX) jumped 26.4% on Friday following comments by researchers at Sinovac, a Chinese drug developer that's collaborating with Dynavax on a COVID-19 vaccine.
In April, Dynavax and Sinovac agreed to collaborate to develop a vaccine for COVID-19. Dynavax is contributing an adjuvant that can boost immune responses in vaccinated patients, while Sinovac is contributing an inactivated coronavirus vaccine candidate.
Image source: Getty Images.
Source Fool.com
